Synthroid — Class II drug recall D-107-2013
Terminated recall by Abbott Laboratories, reported 2013-01-09, distributed nationwide. Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tab
| Recall number | D-107-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abbott Laboratories, Abbott Park, IL, United States |
| Recall initiated | 2012-12-04 |
| Classified | 2012-12-28 |
| Reported by FDA | 2013-01-09 |
| Terminated | 2015-07-10 |
| Distributed | Nationwide (US) |
| Reason classes | labeling, potency |
| NDC | 00074-3727, 00074-3727-13, 00074-3727-19, 00074-3727-71, 00074-3727-72, 00074-3727-90, 00074-4341, 00074-4341-13, 00074-4341-19, 00074-4341-72, 00074-4341-90, 00074-4552, 00074-4552-11, 00074-4552-13, 00074-4552-19, 00074-4552-71, 00074-4552-72, 00074-4552-90, 00074-5182, 00074-5182-11, 00074-5182-13, 00074-5182-19, 00074-5182-71, 00074-5182-72, 00074-5182-90 and 47 more |
| Lot numbers | 09/13, 18262A8 |
Product
Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.
Reason for recall
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-107-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.